HLAG ELISA Kit
-
- Target Alle HLAG ELISA Kits anzeigen
- HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
-
Reaktivität
- Human
- Nachweismethode
- Colorimetric
- Methodentyp
- Sandwich ELISA
- Detektionsbereich
- 0.625 ng/mL - 40 ng/mL
- Untere Nachweisgrenze
- 0.625 ng/mL
- Applikation
- ELISA
- Verwendungszweck
- Human Major Histocompatibility Complex Class I G ELISA Kit is an ELISA Kit against Major Histocompatibility Complex Class I G.
- Proben
- Plasma, Serum
- Analytische Methode
- Quantitative
- Sensitivität
- 0.375 ng/mL
- Featured
- Zu unserem meistverkauften HLAG ELISA Kit
- Top Product
- Discover our top product HLAG ELISA Kit
-
-
- Applikationshinweise
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
- Plattentyp
- Pre-coated
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
- Haltbarkeit
- 6 months
-
- Target Alle HLAG ELISA Kits anzeigen
- HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
- Andere Bezeichnung
- Major Histocompatibility Complex Class I G (HLAG Produkte)
- Synonyme
- MHC-G ELISA Kit, B-F ELISA Kit, B-F-S04 ELISA Kit, B-F-S05 ELISA Kit, B-F-S06 ELISA Kit, B-F-S07 ELISA Kit, B-FI ELISA Kit, B-FIV ELISA Kit, BF2 ELISA Kit, BFa2 ELISA Kit, BFw-03 ELISA Kit, BFw-05 ELISA Kit, BFz-01 ELISA Kit, major histocompatibility complex, class I, G ELISA Kit, MHC BF1 class I ELISA Kit, HLA-G ELISA Kit, BF1 ELISA Kit
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-